SG/CALL/AMGEN/330/0.1/21.06.24 | Market Closed - Deutsche Boerse AG 12:54:57 2024-06-13 EDT | ||
| 0.001 EUR | 0.00% |
|
| Current month | -98.73% | ||
| 1 month | -99.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 0.001 | 0.00% |
| 24-06-12 | 0.001 | 0.00% |
| 24-06-11 | 0.001 | 0.00% |
| 24-06-10 | 0.001 | -94.12% |
| 24-06-07 | 0.017 | -55.26% |
Delayed Quote Deutsche Boerse AG
Last update June 13, 2024 at 12:54 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ3S4Y |
| ISIN | DE000SQ3S4Y1 |
| Date issued | 2022-11-03 |
| Strike | 330 $ |
| Maturity | 2024-06-21 (5 Days) |
| Parity | 10 : 1 |
| Emission price | 1.96 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.98 € |
|---|---|
| Lowest since issue | 0.001 € |
| Delta | 0.05x |
| Omega | 39.98 |
| Premium | 11.66x |
| Gearing | 857.04x |
| Moneyness | 0.8965 |
| Difference Strike | 31.38 $ |
| Difference Strike % | +9.51% |
| Spread | 0.062 € |
| Spread % | 98.41% |
| Intrinsic value | 0.000000 |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Warrants
- Warrant
